This website uses cookies to ensure you have the best experience. Learn more

Pharmaceutical Manufacturing: Prevention Of Cross Comtamination

1650 words - 7 pages

Prevention of cross contamination: Contamination is the presence of undesired materials on a surface or fluid, here are some examples of sources of contamination; people, raw materials, air, and water. These should be prevented from occurring as it as a high risk safety effect on patients and it should be considered from design stage. This can be prevented from occurring by implementing, monitoring and following rules which are;
- SOP must be followed at all times.
- Any changes to the SOP must be documented and recorded (GDP).
- SOP must be detailed (should have equipment name and number, type, date approved, revision number, change history if any, process and operation steps, name, etc)
- PPE must be worn at all times.
- No eating or drinking in the production area.
- Only trained and competent personnel should operate on equipment.
- Equipment must be labelled and identified correctly.
- Raw materials must be inspected and testing before and after use.
- Tests must be carried out at each process stages, so as to safe guide cross contamination. If this do happen, it will be easily identified at that stage, when, where and what might have gone wrong.
- After production, equipment must be cleaned properly and tested for cross contamination (GMP).
- Air going in and out of production should be controlled by using filters e.g. HEPA.
- Final product must be tested, to ensure that there are no contaminations in the product.
- Packaging and labelling must be done correctly.
Validation: Is the documented act of demonstrating that an activity will consistently lead to the expected results while meeting regulatory requirements. It requires a minimum of 3 batches to run simultaneously with an error. If an error occurs at anytime, validation is void and another 3 batches must be carried out. With new cGMP, just 3 batches is not enough, a system or process should show consistently that the process or system is continuously within validation specification.
The above diagram shows the documentation that should be referenced to when generating qualification protocols.
- URS - Is a document that outlines a company’s specific requirements for a system or equipment they wish to purchase. This document contains the followings (overview of the process, process impact, operational, hardware and software, P&ID, training and EHS requirements and vendor deliverables).
- FS - This is a detailed document on how the vendor is going to meet the specific requirements of the URS. This can also include price and conditions of supply.
- DQ - This is a comparison of the detailed URS with the functional specification and we can determine if there are any gaps in the proposed system elements detailed by the vendor and the risk can be evaluated.
- FAT - Confirms the suitability of the system or equipment prior to delivery to the company, should include well documented testing, acceptance criteria and mechanisms for disaster recovery testing and...

Find Another Essay On Pharmaceutical Manufacturing: Prevention of Cross Comtamination

Mental Models/Mindsets Paper

753 words - 3 pages breakthrough medicines; providing information on prevention, wellness, and treatment; consistent high-quality manufacturing of medicines, consumer products; and global leadership in corporate responsibility" (Pfizer, 2007). They recognize that people are the cornerstone of Pfizer's success, they value their diversity as a source of strength, and they are proud of Pfizer's history of treating people with respect and dignity.Pfizer is deeply committed

KV Pharmaceuticals Case Study

4368 words - 17 pages sulfate pills, a pain-relief medication (KV Pharmaceutical, 2010). One month later, KV decided to recall some of the morphine sulfate it had distributed, and it also filed a field alert report to the FDA informing them about their recall. KV immediately began an internal investigation of their manufacturing process and their products; the investigation revealed that not only were the morphine sulfate pills oversized, but the propafenone and

biomedical engineering

870 words - 4 pages involved in the conception, design, construction, and operation of research facilities and manufacturing plants, where they also are involved in the conception, design, scale-up, manufacturing, and labeling and packaging processes in the conversion of chemical and biological materials into valuable pharmaceuticals and pharmaceutical therapies. A wide variety of careers in each sector of the industry including research of new drugs and drug delivery

Pharmecutical Companies: Are they overcharging?

629 words - 3 pages percent in 2002 was 36.6 and Pixar's was about 44%. The leader in the pharmaceutical industry on percent net profit was Pfizer with a profit of about 28%, and the lowest of these was Bristol-Meyers-Squibb with a percent profit of about 12%. When comparing the total cost of manufacturing and the percent of profit the pharmaceutical companies are really not gaining that much profit ( Against the

GlaxoSmithKline's Corporate Social Responsibility Practices

4251 words - 17 pages Table of contents:1) Introduction.2) Pharmaceutical sector in general, main arguments put forward by the companies and counter-arguments.3) GlaxoSmithKlein's CSR claims and counter-evidence:i) Medicines for the developing world.ii) Business ethics and integrity.iii) Environment, health and safety.iv) Research and development.4) Concluding remarks.5) References.6) Appendices.1. Introduction.The global pharmaceutical industry has long been

Drug Discovery

959 words - 4 pages Drug is a chemical which alters the processes in the organism, which is used in the medicine for prevention, diagnosis and treatment of the diseases (Farlex, 2011). Drug discovery is a long term process that needs money investment. The process of drug investigation takes approximately from 9 to 15 years during which the number of chemicals that can become drug is reduced from 10,000 to 1-2 (Saparov, 2011). Even after manufacturing the drug is

International business of ABC pharmaceutical firm

2275 words - 9 pages 1. Introduction.ABC pharmaceutical firm is a small Asian firm in China; the firm has its own factory which 200 workers factory. The company currently developed some valuable new medical products using its unique biotechnology expertise. The top managers of the firm want to expend the market and decide how to best serve the European Community market. The company has three options:a. Manufacture the product at home and let foreign agents

A Strategic Analysis of Novartis

1036 words - 5 pages industry. Companies must innovate and stay current in their practices in order to gain a competitive advantage. The next KSF includes each companies Patents and Drug Portfolio (JJ - High, P - Low, N - High, and M - Average). This KSF is the lifeblood of pharmaceutical companies. The third KSF is Distribution and Logistics (JJ - High, P - High, N - High, and M - High). Being able to procure the necessary inputs for drug manufacturing is essential in the

Pharmaceutical Companies Stand in the Way of Treatment

3821 words - 15 pages " (Dugger, par 3). Many of the poor countries lack the factories and manufacturing capability for producing these drugs and, thus, have no other choice than to comply with the price demands of the multinational pharmaceutical giants. A solution would be to allow countries with no domestic manufacturing capability to import cheaper generic drugs from other countries. For instance, while Pfizer sells, Diflucan, the drug used to treat

Pfizer: An Economic Report

4487 words - 18 pages of developing new pharmaceutical drugs in the Twentieth Century. An example of cost savings is shipping manufacturing plants offshore. This not only changes the American economy, but has a significant impact on the global economy as well. It is not enough to make a better 'pill', but it has to be made smarter. This involves revamping factories to save money and avoiding production mishaps. Healthcare and life sciences companies are going through

Future of "Big Pharma"

2421 words - 10 pages Subject: Pharmaceutical Industry. - "Big Pharma"Problem: The main problem is more than $80 billion worth of blockbuster drugs faces patent expiration by 2008. These drugs risk losing 80% or greater market share when generic copies hit the market. With the industry developing fewer blockbuster drugs today, it is of grave importance that pharmaceutical companies protect those drugs whose revenue streams will enable them to keep developing new

Similar Essays

Preventing Crosscontamination In Pharmaceutical Production Essay

1951 words - 8 pages purchasing stage till manufacturing, packaging materials and operation. Also the quality of the finishing product, rejecting of raw material or end product and returned materials. Due to the word limitation of this assignment exploring each are of the above will be brief. Discussion 1-Prevention of cross contamination Cross contamination in pharmaceutical production should be prevented at all the stages of production. It is defined as: “The

Decisions In Paradise Part I Essay

1121 words - 4 pages Decisions in paradise Part I PAGE \* MERGEFORMAT 5 Running head: Decisions in Paradise Part IDecisions in Paradise Part IA graduate student named Nick has accepted what seems to be an opportunity of a lifetime to work with Aventis Pharmaceutical, a world leader in pharmaceutical products. His role was to be an assistant to the director of strategic planning. Aventis Pharmaceutical offers number of vaccines, which can prevent various diseases

The High Cost Of Branded Drugs In The United States

1049 words - 5 pages percentage of charges per case appointment. Yet approximately vital medications are out of stock or of uncertain value. China's medication rating restructuring requires implementation in organization with hospital finance reform and health indemnity growth. CONTRADICTORY GOALS PLAGUE --China's pharmaceutical policy. The administration desires to enlarge the marital medicinal manufacturing and endorse modernization. In addition, cut administration backing of the

The Global Pharmaceutical Market Forecast Essay

2415 words - 10 pages specific countries, cross-country regression analyses for OECD countries indicated that the income elasticity of demand for health care expenditures ranges from 1.31.8, meaning a 1% increase in per capita income in these countries is likely to result in a 1.3-1.8% increase in health care spending (106). Evidences suggest that pharmaceutical demand is price inelastic but income elastic. This explains the price discrimination between countries